Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sasieni

Showing results (11-20 of 210) with videos related to

Pageof 21
Sort By:
BMJ (Clinical Research Ed.)|June 16, 2026
Vaccination is helping to eliminate cervical cancer in several countries, and continued surveillance is essentialPeter Sasieni, Juliet Rix
Lancet (London, England)|November 9, 2004
Cervical screening in adolescents--at least do no harmAnne Szarewski, Peter Sasieni
Vaccine|July 14, 2020
Evidence of HPV vaccination efficacy comes from more than clinical trialsPeter Sasieni, Alejandra Castanon
Preventive Medicine|December 17, 2017
Is the recent increase in cervical cancer in women aged 20-24years in England a cause for concern?Alejandra Castanon, Peter Sasieni
Lancet (London, England)|July 30, 2003
The UK breast-screening programme should start at age 47 yearsPeter Sasieni, Jack Cuzick
British Journal of Cancer|September 14, 2022
Interpreting the results of noninferiority trials-a reviewJack Cuzick, Peter Sasieni
BMJ (Clinical Research Ed.)|May 25, 2011
Safe thresholds for hybrid capture 2 test in primary cervical screeningPeter Sasieni, Alejandra Castanon
Lancet (London, England)|May 29, 2018
When should the errors in the UK's breast screening programme have been spotted?Shama Sheikh, Peter Sasieni
Lancet (London, England)|January 24, 2020
Population-level impact of human papillomavirus vaccinationPeter Sasieni, Jack Cuzick
Lancet (London, England)|May 22, 2022
HPV vaccination and cervical cancer screening - Authors' replyPeter Sasieni, Alejandra Castanon
Pageof 21

Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
BMJ (Clinical Research Ed.)|June 16, 2026
Vaccination is helping to eliminate cervical cancer in several countries, and continued surveillance is essentialPeter Sasieni, Juliet Rix
Lancet (London, England)|November 9, 2004
Cervical screening in adolescents--at least do no harmAnne Szarewski, Peter Sasieni
Vaccine|July 14, 2020
Evidence of HPV vaccination efficacy comes from more than clinical trialsPeter Sasieni, Alejandra Castanon
Preventive Medicine|December 17, 2017
Is the recent increase in cervical cancer in women aged 20-24years in England a cause for concern?Alejandra Castanon, Peter Sasieni
Lancet (London, England)|July 30, 2003
The UK breast-screening programme should start at age 47 yearsPeter Sasieni, Jack Cuzick
British Journal of Cancer|September 14, 2022
Interpreting the results of noninferiority trials-a reviewJack Cuzick, Peter Sasieni
BMJ (Clinical Research Ed.)|May 25, 2011
Safe thresholds for hybrid capture 2 test in primary cervical screeningPeter Sasieni, Alejandra Castanon
Lancet (London, England)|May 29, 2018
When should the errors in the UK's breast screening programme have been spotted?Shama Sheikh, Peter Sasieni
Lancet (London, England)|January 24, 2020
Population-level impact of human papillomavirus vaccinationPeter Sasieni, Jack Cuzick
Lancet (London, England)|May 22, 2022
HPV vaccination and cervical cancer screening - Authors' replyPeter Sasieni, Alejandra Castanon
Pageof 21